Skip to main content
Log in

Microvascular decompression surgery is effective for the laterocollis subtype of spasmodic torticollis: a long-term follow-up result

  • Clinical Article - Functional
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Spasmodic torticollis (ST) is characterized by sustained, involuntary, and painful spasms of specific muscle (s), which results into abnormal posture of the neck and head. Although various treatments for ST have been introduced, none of them shows absolute effectiveness. Earlier research from our department showed that microvascular decompression (MVD) surgery is effective in the short-term for ST patients with confirmed accessory nerve compression. However, the long-term outcome of MVD remains unknown.

Method

Twelve ST patients with confirmed accessory nerve compression received MVD surgery of their accessory nerves. We utilized the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) to evaluate the long-term outcome (5.4 ± 0.87 years).

Results

The MVD lowered total TWSTRS scores by 42.8 % in all ST patients. This result, however, only counted for moderate relief. Interestingly, we observed that the laterocollis (LC) subtypes of ST (n = 3) obtained a higher TWSTRS score improvement (86.9 ± 6.2 %), compared to that of the non-LC (28.1 ± 12 %) (P =0.0001). Additionally, the disability (92.7 ± 2 %) subscale score in the LC subtypes had the most prominent improvement compared to the pain (88.1 ± 5.1 %) and severity (81.3 ± 10.5 %).

Conclusions

In the cases of confirmed accessory nerve compression, the MVD could be considered as a treatment alternative for ST, especially for the LC subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Alafaci C, Salpietro FM, Montemagno G, Grasso G, Tomasello F (2000) Spasmodic torticollis due to neurovascular compression of the spinal accessory nerve by the anteroinferior cerebellar artery: case report. Neurosurgery 47:768–771, discussion 771–772

    CAS  PubMed  Google Scholar 

  2. Albanese A, Asmus F, Bhatia K, Elia A, Elibol B, Filippini G, Gasser T, Krauss J, Nardocci N, Newton A, Valls-Solé J (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5–18

    Article  CAS  PubMed  Google Scholar 

  3. Brashear A, Lew M, Dykstra D, Comella C, Factor S, Rodnitzky R, Trosch R, Singer C, Brin M, Murray J, Wallace J, Willmer-Hulme A, Koller M (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53:1439–1446

    Article  CAS  PubMed  Google Scholar 

  4. Chan J, Brin M, Fahn S (1991) Idiopathic cervical dystonia: clinical characteristics. Mov Disord 6:119–126

    Article  CAS  PubMed  Google Scholar 

  5. Comella C, Stebbins G, Goetz C, Chmura T, Bressman S, Lang A (1997) Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 12:570–575

    Article  CAS  PubMed  Google Scholar 

  6. Dressler D (2004) Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov Disord 19:S92–S100

    Article  PubMed  Google Scholar 

  7. Dressler D, Paus S, Seitzinger A, Gebhardt B, Kupsch A (2013) Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia. J Neurol Neurosurg Psychiatry 84:1014–1019

    Article  PubMed Central  PubMed  Google Scholar 

  8. Fahn S (1988) Concept and classification of dystonia. Adv Neurol 50:1–8

    Article  CAS  PubMed  Google Scholar 

  9. Ferroli P, Fioravanti A, Schiariti M, Tringali G, Franzini A, Calbucci F, Broggi G (2009) Microvascular decompression for glossopharyngeal neuralgia: a long-term retrospective review of the Milan-Bologna experience in 31 consecutive cases. Acta Neurochir (Wien) 151:1245–1250

    Article  Google Scholar 

  10. Freckmann N, Hagenah R, Herrmann HD, Muller D (1981) Treatment of neurogenic torticollis by microvascular lysis of the accessory nerve roots - indication, technique, and first results. Acta Neurochir (Wien) 59:167–175

    Article  CAS  Google Scholar 

  11. Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K (1986) Brain neurotransmitters in dystonia musculorum deformans. N Engl J Med 315:347–353

    Article  CAS  PubMed  Google Scholar 

  12. Jho HD, Jannetta PJ (1995) Microvascular decompression for spasmodic torticollis. Acta Neurochir (Wien) 134:21–26

    Article  CAS  Google Scholar 

  13. Jost W, Hefter H, Stenner A, Reichel G (2013) Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy. J Neural Transm 120:487–496

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Kessler K, Skutta M, Benecke R (1999) Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group J Neurol 246:265–274

    CAS  Google Scholar 

  15. Kutvonen O, Dastidar P, Nurmikko T (1997) Pain in spasmodic torticollis. Pain 69:279–286

    Article  CAS  PubMed  Google Scholar 

  16. Lal S (1979) Pathophysiology and pharmacotherapy of spasmodic torticollis: a review. Can J Neurol Sci 6:427–435

    CAS  PubMed  Google Scholar 

  17. Lee M (1992) Spasmodic torticollis: medical and botulinum A toxin treatment. Yonsei Med J 33:289–293

    CAS  PubMed  Google Scholar 

  18. Lew M, Adornato B, Duane D, Dykstra D, Factor S, Massey J, Brin M, Jankovic J, Rodnitzky R, Singer C, Swenson M, Tarsy D, Murray J, Koller M, Wallace J (1997) Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49:701–707

    Article  CAS  PubMed  Google Scholar 

  19. Lindeboom R, Brans J, Aramideh M, Speelman H, De Haan R (1998) Treatment of cervical dystonia: a comparison of measures for outcome assessment. Mov Disord 13:706–712

    Article  CAS  PubMed  Google Scholar 

  20. Love S, Coakham H (2001) Trigeminal neuralgia: pathology and pathogenesis. Brain 124:2347–2360

    Article  CAS  PubMed  Google Scholar 

  21. McKenzie K (1924) Intrameningeal division of the spinal accessory and roots of the upper cervical nerves for the treatment of spasmodic torticollis. Surg Gynecol Obstet 39:5–10

    Google Scholar 

  22. McLaughlin N, Buxey F, Chaw K, Martin N (2014) Value-based neurosurgery: the example of microvascular decompression surgery. J Neurosurg 120:462–472

    Article  PubMed  Google Scholar 

  23. Miller L, Miller V (2012) Safety and effectiveness of microvascular decompression for treatment of hemifacial spasm: a systematic review. Br J Neurosurg 26:438–444

    Article  PubMed  Google Scholar 

  24. Münchau A, Palmer J, Dressler D, O’Sullivan J, Tsang K, Jahanshahi M, Quinn N, Lees A, Bhatia K (2001) Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia. Brain 124:769–783

    Article  PubMed  Google Scholar 

  25. Munts A, Koehler P (2010) How psychogenic is dystonia? Views from past to present. Brain 133:1552–1564

    Article  PubMed  Google Scholar 

  26. Naber D, Weinberger DR, Bullinger M, Polsby M, Chase TN (1988) Personality variables, neurological and psychopathological symptoms in patients suffering from spasmodic torticollis. Compr Psychiatry 29:182–187

    Article  CAS  PubMed  Google Scholar 

  27. Reichel G (2011) Cervical dystonia: a new phenomenological classification for botulinum toxin therapy. Basal Ganglia 1:5–12

    Article  Google Scholar 

  28. Reichel G, Stenner A, Jahn A (2009) The phenomenology of cervical dystonia. Fortschr Neurol Psychiatr 77:272–277

    Article  CAS  PubMed  Google Scholar 

  29. Scheidt CE, Rayki O, Nickel T, Heinen F, Wissel J, Poewe W, Benecke R, Arnold G, Oertel W, Dengler R, Deuschl G (1998) Psychosomatic aspects of idiopathic spasmodic torticollis. Results of a multicenter study. Psychother Psychosom Med Psychol 48:1–12

    CAS  PubMed  Google Scholar 

  30. Schjerling L, Hjermind L, Jespersen B, Madsen F, Brennum J, Jensen S, Løkkegaard A, Karlsborg M (2013) A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia. J Neurosurg 119:1537–1545

    Article  PubMed  Google Scholar 

  31. Schmidt A, Klein C (2010) The role of genes in causing dystonia. Eur J Neurol Jul; 17:65–70

    Article  Google Scholar 

  32. Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y (2008) Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699–1706

    Article  CAS  PubMed  Google Scholar 

  33. Smith D, DeMario M (1996) Spasmodic torticollis: a case report and review of therapies. J Am Board Fam Pract 9:435–441

    CAS  PubMed  Google Scholar 

  34. Smith P, Meaney J, Graham L, Stoker J, Mackintosh A, Mary D, Ball S (2004) Relationship of neurovascular compression to central sympathetic discharge and essential hypertension. J Am Coll Cardiol 43:1453–1458

    Article  PubMed  Google Scholar 

  35. Sun K, Lu Y, Hu G, Luo C, Hou L, Chen J, Wu X, Mei Q (2009) Microvascular decompression of the accessory nerve for treatment of spasmodic torticollis: early results in 12 cases. Acta Neurochir (Wien) 151:1251–1257

    Article  Google Scholar 

  36. Taira T (2004) Spasmodic torticollis. J Neurosurg 100:170–171; author reply 172

  37. Tarsy D (1997) Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 12:100–102

    Article  CAS  PubMed  Google Scholar 

  38. Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL (2005) Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord 20:783–791

    Article  PubMed  Google Scholar 

  39. van den Dool J, Visser B, Koelman JH, Engelbert RH, Tijssen MA (2013) Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial. BMC Neurol 13:85

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Prof. Marc Sindou for his comments and encouragement of our report four years ago, inspiring us to improve this work.

Conflicts of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lijun Hou.

Additional information

Qiyong Mei, Chunfang Zhang and Ying Jiang contributed equally to this publication.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mei, Q., Zhang, C., Jiang, Y. et al. Microvascular decompression surgery is effective for the laterocollis subtype of spasmodic torticollis: a long-term follow-up result. Acta Neurochir 156, 1551–1556 (2014). https://doi.org/10.1007/s00701-014-2120-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-014-2120-y

Keywords

Navigation